mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |